IRIS
BALBI, MATILDE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.075
NA - Nord America 858
AS - Asia 847
Continente sconosciuto - Info sul continente non disponibili 126
SA - Sud America 63
AF - Africa 16
OC - Oceania 1
Totale 4.986
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 2.938
US - Stati Uniti d'America 800
SG - Singapore 302
CN - Cina 202
VN - Vietnam 135
BD - Bangladesh 118
HK - Hong Kong 40
BR - Brasile 36
CA - Canada 32
FR - Francia 23
GB - Regno Unito 23
AR - Argentina 16
DE - Germania 14
FI - Finlandia 14
NL - Olanda 11
JP - Giappone 9
PL - Polonia 9
IN - India 8
JM - Giamaica 6
MX - Messico 6
ES - Italia 5
IQ - Iraq 5
TT - Trinidad e Tobago 5
ZA - Sudafrica 5
PH - Filippine 4
SI - Slovenia 4
TR - Turchia 4
UA - Ucraina 4
CH - Svizzera 3
CO - Colombia 3
EC - Ecuador 3
ID - Indonesia 3
NP - Nepal 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
BB - Barbados 2
BE - Belgio 2
CL - Cile 2
CR - Costa Rica 2
DZ - Algeria 2
GR - Grecia 2
HN - Honduras 2
IE - Irlanda 2
IL - Israele 2
KE - Kenya 2
KR - Corea 2
LT - Lituania 2
MD - Moldavia 2
RO - Romania 2
RU - Federazione Russa 2
SE - Svezia 2
VE - Venezuela 2
AL - Albania 1
AO - Angola 1
AU - Australia 1
BO - Bolivia 1
CG - Congo 1
CY - Cipro 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
JO - Giordania 1
LB - Libano 1
MA - Marocco 1
MT - Malta 1
NO - Norvegia 1
PK - Pakistan 1
RS - Serbia 1
SA - Arabia Saudita 1
SC - Seychelles 1
SN - Senegal 1
YT - Mayotte 1
Totale 4.860
Salva come PNG Salva come JPEG
Città #
Genoa 1.640
Genova 532
Vado Ligure 364
San Jose 213
Rapallo 196
Singapore 164
Ashburn 105
Ho Chi Minh City 43
Beijing 41
Hong Kong 40
Council Bluffs 31
Hanoi 31
New York 27
Los Angeles 26
Rome 23
Santa Clara 21
Lauterbourg 19
Helsinki 13
Milan 13
Turin 13
Bordighera 12
Chicago 12
Buffalo 11
Montreal 11
Boardman 10
Da Nang 10
St Louis 10
Haiphong 9
Naples 9
Orem 9
Frankfurt am Main 8
Staten Island 8
Miami 7
Boston 6
Dallas 6
Piscataway 6
São Paulo 6
Toronto 6
Atlanta 5
Baghdad 5
Bari 5
Phoenix 5
Tokyo 5
Amsterdam 4
Baltimore 4
Basingstoke 4
Houston 4
Kingston 4
Krakow 4
Kyiv 4
Ljubljana 4
London 4
Madrid 4
Mexico City 4
Palermo 4
Tampa 4
Tianjin 4
Birmingham 3
Bratislava 3
Bến Tre 3
Castellana Grotte 3
Cisano Bergamasco 3
Denver 3
Detroit 3
Florence 3
Hải Dương 3
Leipzig 3
Malatya 3
Newark 3
Osio Sopra 3
Padua 3
Phủ Lý 3
Pisa 3
San Salvador 3
Shanghai 3
Sherwood Park 3
Warsaw 3
Winnipeg 3
Zurich 3
Ahmedabad 2
Athens 2
Avezzano 2
Bitonto 2
Bologna 2
Braga 2
Bridgetown 2
Bridgewater 2
Brooklyn 2
Buenos Aires 2
Can Tho 2
Charlotte 2
City of London 2
Columbus 2
Curitiba 2
Dhaka 2
Dublin 2
Erie 2
Falconara Marittima 2
Fort Myers 2
Johannesburg 2
Totale 3.900
Salva come PNG Salva come JPEG
Nome #
Presynaptic GLP-1 receptors enhance the depolarization-evoked release of Glutamate and GABA in the mouse cortex and hippocampus 244
Memory-enhancing effects of GEBR-32a, a new PDE4D inhibitor holding promise for the treatment of Alzheimer’s disease. 217
Group I metabotropic glutamatergic receptors regulating glutamate release and microglia phenotype in a murine model of amyotrophic lateral sclerosis 203
Enhanced Function and Overexpression of Metabotropic Glutamate Receptors 1 and 5 in the Spinal Cord of the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis during Disease Progression 188
The complex phenotype and function of spinal cord microglia during ALS progression and the impact of metabotropic glutamate receptor type 5 down-regulation in SOD1G93A mice 162
In-vivo therapeutic effects of extracellular vesicles derived from mesenchymal stem after systemic administration on ALS mice 146
GEBR-32A, A NEW PROMISING PDE4D INHIBITOR FOR TREATMENT OF ALZHEIMER'S DISEASE 140
Changes at glutamate tripartite synapses in the prefrontal cortex of a new animal model of resilience/vulnerability to acute stress 140
Blocking glutamate mGlu5 receptors with the negative allosteric modulator CTEP improves disease course in SOD1G93A mouse model of amyotrophic lateral sclerosis 133
In-vivo and in-vitro evidence supporting the role of mGlu5 receptor as a key regulator of glutamate downstream effects in ALS 127
Preclinical study showing a gender specific protective properties of conjugated linoleic acid (CLA) for amyotrophic lateral sclerosis 126
In-vitro and in-vivo studies depict metabotropic glutamate receptor 5 as a potential pharmacological target to modulate disease progression in ALS 126
Genetic Downregulation of the Metabotropic Glutamate Receptor Type 5 Dampens the Reactive and Neurotoxic Phenotype of Adult ALS Astrocytes 118
Glucagon Like Peptide-1 increases glutamate release in the mouse cerebral cortex and hippocampus by activacting presynaptic GLP-1R 118
Efficacy and Safety of Visible and Near-Infrared Photobiomodulation Therapy on Astenospermic Human Sperm: Wavelength-Dependent Regulation of Nitric Oxide Levels and Mitochondrial Energetics 115
null 114
Phenotype changes of microglia in SOD1G93A mice after mGluR5 genetic down regulation 112
Genetic and pharmacological effects by blocking mGlu5 receptor in the SOD1G93A mouse model of amyotrophic lateral sclerosis 111
cGMP MODULATES LONG-TERM POTENTIATION AND MEMORY BY ENHANCING ABETA PRODUCTION 111
microRNAs shuttled by extracellular vesicles derived from mesenchymal stem cells rescue glial activation in in-vitro models of amyotrophic lateral sclerosis 105
The Physio-Pathological Role of Group I Metabotropic Glutamate Receptors Expressed by Microglia in Health and Disease with a Focus on Amyotrophic Lateral Sclerosis 103
Reducing mglur5 expression attenuates the reactive phenotype of astrocytes cultured from the spinal cord of late symptomatic SOD1G93A mice 103
Therapeutic effects of MSC-derived EVs intranasally administered on ALS mice 100
In-vitro and in-vivo evidence supporting the therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis 94
MSC-derived extracellular vesicles for the treatment of ALS 91
The investigational anti-B7-H3 antibody-drug conjugate vobramitamab duocarmazine exerts anti-tumor activity in vitro and in vivo in pediatric sarcoma preclinical models 91
Chromosomal Deletion Involving ANKRD26 Leads to Expression of a Fusion Protein Responsible for ANKRD26-Related Thrombocytopenia 89
Multiple approaches reveal altered lipid metabolism, neurotransmitter release and nervous conduction in a zebrafish model of Alexander Disease 87
In-vitro and in-vivo evidence supporting the therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis 85
PRESYNAPTIC GLP-1 RECEPTORS ENHANCE GLUTAMATE AND GABA RELEASE FROM PURIFIED MOUSE CORTICAL AND HIPPOCAMPAL SYNAPTOSOMES 83
microRNAs shuttled by extracellular vesicles derived from mesenchymal stem cells revert glial activation and neurotoxicity in in-vitro models of amyotrophic lateral sclerosis 81
The mGlu5 receptor negative allosteric modulator CTEP as a pharmacological tool to dampen ALS disease progression: in-vivo preclinical studies and clinical perspectives 79
Therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis 77
In-vitro and in-vivo studies showing the beneficial effects of extracellular vesicles derived from mesenchymal stem cells on the reactive astrocyte activation in amyotrophic lateral sclerosis 77
Sex-specific motor and behavioural parameters for early stratification of ALS progression in SOD1(G93A) mice. 74
Combined motor and behavioural tracking approach to stratify ALS progression in SOD1(G93A) mice. 74
Synapto-gliosomal characterization in a zebrafish model of Alexander disease 73
Partial deletion of mGluR5 affects M1 and M2 phenotypes in microglia acutely isolated from SOD1(G93A) mice during disease progression 72
Partial deletion of mGluR5 affects microglia inflammatory phenotype, bioenergetic characteristics, and red-ox state during ALS progression in SOD1G93A mice 71
Changes of the microglia phenotype in the SOD1G93A mouse model of amyotrophic lateral sclerosis after mGluR5 genetic down-regulation 71
Intranasal in-vivo administration of MSC-derived EVs on ALS mice 66
Phenotype changes of spinal cord microglia cells acutely purified from SOD1G93AALS mice during disease progression: focus on the genetic down regulation of mGlu5 receptor 64
Molecular signatures of astrocytes and microglia maladaptive responses to acute stress are rescued by a single administration of ketamine in a rodent model of PTSD 63
Preventive effects of conjugated linoleic acid (CLA) in-vivo oral treatment in the SOD1G93A preclinical model of amyotrophic lateral sclerosis 63
miR-29a-3p and TGF-β Axis in Fanconi anemia: mechanisms driving metabolic dysfunction and genome stability 52
Local Insulin for Local Needs? Insights into Retinal Insulin Signaling and RPE Metabolism 51
The partial deletion of mGluR5 affects the pro- and anti-inflammatory and bioenergetic characteristics of microglia during ALS progression in SOD1(G93A) mice 46
Fanconi Anemia: Interplay Between DNA Repair Defects, Mitochondrial Dysfunction, and Oxidative Stress 20
Nearly 30 years of animal models to study amyotrophic lateral sclerosis: A historical overview and future perspectives. 11
Beyond readthrough: ataluren restores mitochondrial function and reduces oxidative stress in FANCA-mutated cells via mTOR–DRP1 modulation 9
The impact of near-infrared photobiomodulation therapy on human oocyte rescue in vitro maturation 7
null 1
null 1
Therapeutic efficacy of extracellular vesicles from hiPSC-derived MSCs in serum-containing and xeno-free media for osteoarthritis treatment 1
Totale 4.986
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.663
article - articoli 6.278
book - libri 0
conference - conferenze 8.907
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.848
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022182 1 8 13 11 7 10 23 37 17 16 17 22
2022/2023245 24 20 7 19 21 28 2 22 50 6 44 2
2023/2024301 6 23 23 32 29 48 19 18 4 20 28 51
2024/20251.045 56 47 24 80 105 93 107 183 33 68 109 140
2025/20262.564 246 79 171 184 314 114 310 198 247 255 204 242
2026/2027243 243 0 0 0 0 0 0 0 0 0 0 0
Totale 4.986